A growing body of evidence supports the notion that dysregulations in Anxa1 expression play a critical role in the pathogenesis of cancer, encompassing tumor development, invasion, metastasis, initiation, and acquired resistance to therapies. This evidence concerns the gene ANXA1 and neoplasm.